Earnings Call · Q1 FY2024·2024-05-06

Q1 24EPS -80.00%·Rev n/aQ4 23EPS +100.00%*·Rev n/aQ3 23EPS 0.00%·Rev n/aQ2 23EPS -68.92%·Rev n/a⚠ consensus missing

Krystal Biotech, Inc. KRYS

Stéphane Paquette — Vice President of Corporate Development

Krish Krishnan — Chief Executive Officer

Jennifer McDonough — Head of Patient Access

Christine Wilson — Head of Commercial Operations

Suma Krishnan — Chief Scientific Officer

Kathryn Romano — Chief Financial Officer

−2.6%1d on move date−3.6% vs SPY3d−2.1%5d−3.9%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more KRYS calls or request research access.

More KRYS calls Browse calls Request research access